Pasireotide-d7

Isotope labelled Pasireotide. Pasireotide is a synthetic long-acting cyclic hexapeptide with somatostatin-like activity. It is marketed as a diaspartate salt called Signifor®, which is used in the treatment of Cushing's disease.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	10-101-197
CAS	396091-73-9 (non-labelled)
Synonyms/Alias	Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7; SOM 230-d7SOM 320-d7; Signifor-d7;
M.F/Formula	C₅₈H₅₉D₇N₁₀O₉
M.W/Mr.	1054.25
Sequence	Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl]-d7
Labeling Target	Somatostatin receptor
Application	Pasireotide-d7 is invesgated for the treatment of Cushing's disease, specifically for those patients whom pituitary surgery has not been curative or is not an option.
Purity	98.0 % min
Functions	Somatostatin receptor activity

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-169	Pasireotide	1047.20624	C58H66N10O9	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.